PMC3150494_01
Antiretroviral regimens, HIV RNA, CD4 count, and resistance testing results through week 48 of treatment. DOT = directly observed therapy, DRV/r = darunavir plus low-dose ritonavir, EFV = efavirenz, ETR = etravirine, FTC = emtricitabine, RAL = raltegravir, TDF = tenofovir
nihms314793f1.jpg
PMC3150494_01_nihms314793f1.jpg
F1
Figure 1 depicts the patient's antiretroviral regimens, HIV RNA, CD4 count, and resistance testing results up to week 48 of therapy.